These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2099050)

  • 1. Essential hypertension--investigations and management.
    Duggin GG; Tiller DJ
    P N G Med J; 1990 Dec; 33(4):295-300. PubMed ID: 2099050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the pregnant patient with chronic hypertension.
    Hayashi RH
    Clin Ther; 1983; 5(6):568-78. PubMed ID: 6138151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of vascular risk factors in the hypertensive patient.
    Taylor SH
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():10-6. PubMed ID: 2148191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
    CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line therapy for hypertension: different patients, different needs.
    Massie BM
    Geriatrics; 1994 Apr; 49(4):22-30. PubMed ID: 7909305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of drug therapy in hypertension.
    Shetty MA; Hegde BM
    J Indian Med Assoc; 1999 Mar; 97(3):106-9. PubMed ID: 10652911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpharmacological interventions as an adjunct to the pharmacological treatment of hypertension: a statement by WHL. The World Hypertension League.
    J Hum Hypertens; 1993 Apr; 7(2):159-64. PubMed ID: 8510089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension: patient evaluation, indications for treatment.
    Elnicki M; Kotchen TA
    Geriatrics; 1993 Apr; 48(4):47-50, 59-62. PubMed ID: 8462883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of hypertension.
    Reid JL
    Kidney Int Suppl; 1993 Jul; 42():S68-70. PubMed ID: 8361133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity in hypertension: effects on prognosis and treatment.
    Kaplan NM
    J Hypertens Suppl; 1998 Jan; 16(1):S35-7. PubMed ID: 9534095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension: insights from the JNC-VI report.
    Kaplan NM
    Am Fam Physician; 1998 Oct; 58(6):1323-30. PubMed ID: 9803197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factor modification in hypertension--success and failure.
    Curzio JL; Reid JL; Kennedy S; Elliott HL; Rubin PC
    J Hum Hypertens; 1987 Sep; 1(2):131-6. PubMed ID: 2906370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.